(Q39441097)

12 September 2017

Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors (English)

1 reference

12 September 2017

angiogenesis inhibitor

1 reference

6

1 reference

12 September 2017

Z-K Liao

1

1 reference

12 September 2017

K-C Tsai

2

1 reference

12 September 2017

H-T Wang

3

1 reference

12 September 2017

S-H Tseng

4

1 reference

12 September 2017

W-P Deng

5

1 reference

12 September 2017

L-H Hwang

7

1 reference

12 September 2017

18 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

19

1 reference

12 September 2017

3

1 reference

12 September 2017

171-180

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2011.73

12 September 2017

0 references

cites work

Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Gene therapy progress and prospects: ultrasound for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Current status of research on biophysical effects of ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Microbubble-enhanced ultrasound for vascular gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Local delivery of plasmid DNA into rat carotid artery using ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Ultrasound enhances gene delivery of human factor IX plasmid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

The role of the vascular phase in solid tumor growth: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Differences in gene expression between sonoporation in tumor and in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Concurrent delivery of GM‐CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

Induction of cell-membrane porosity by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

7 January 2021

Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

7 January 2021

In vivo gene transfer into muscle via electro-sonoporation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

7 January 2021

Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

7 January 2021

Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

7 January 2021

Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.73

7 January 2021

Identifiers

DOI

10.1038/CGT.2011.73

1 reference

12 September 2017

1 reference